Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
NPJ Genomic Medicine|December 22, 2017
Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndromeSock Hoai Chan, Weng Khong Lim, Scott T Michalski, et al.
BMC Medicine|February 7, 2026
Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphomaJason Yongsheng Chan, Elizabeth Chun Yong Lee, Kelila Xin Ye Chai, et al.
Blood|March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.
British Journal of Haematology|February 1, 2020
Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphomaDachuan Huang, Tammy Linlin Song, Maarja-Liisa Nairismägi, et al.
Scientific Reports|October 20, 2019
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter studyKhee Ming Tan, Burton Chia, Jing Quan Lim, et al.
Leukemia|December 15, 2018
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphomaRou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, et al.
Cancer Discovery|October 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell LymphomaCheng Huang, Yan Gao, Jianfeng Chen, et al.
Blood|January 3, 2024
Single-cell landscape of idiopathic multicentric Castleman disease in identical twinsJason Yongsheng Chan, Jui Wan Loh, Jing Quan Lim, et al.
Cancer Letters|September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphomaYichen Sun, Yan Gao, Jianfeng Chen, et al.
Gut|September 23, 2019
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinomaWen Fong Ooi, Amrita M Nargund, Kevin Junliang Lim, et al.
Pageof 6